单中心经验:内脏动脉瘤的治疗
这项单中心回顾性研究分析了1992年至2017年125例内脏动脉瘤(VAA)的开放手术或腔内干预结果。腔内治疗占44.8%,技术成功率98.3%,择期手术死亡率均为零,但急诊开放手术死亡率达40%。结论认为急诊首选腔内治疗,择期可根据动脉瘤特征和患者风险选择开放或腔内。
要点
- 急诊VAA优先考虑腔内治疗,因其创伤小、止血快,死亡率低于开放手术。
- 择期VAA中开放手术与腔内治疗死亡率相当,开放手术仍适用于腔内困难且低手术风险者。
- 腔内治疗并发症发生率8.9%,包括动脉瘤再灌注、支架血栓等,需术后随访。
核心结论
- 急诊内脏动脉瘤应首选腔内治疗,择期治疗中开放手术仍适用于腔内困难且低手术风险患者。
研究设计与样本
- 单中心回顾性研究,纳入1992年1月至2017年1月共125例内脏动脉瘤的开放手术或腔内干预。
主要发现
- 腔内治疗56例(44.8%),技术成功率98.3%,无死亡,并发症5例(8.9%)。
- 开放手术69例(55.2%),急诊开放手术20例中8例(40%)术中死亡,择期开放手术无死亡。
关键数值与推荐
- 腔内治疗技术成功率98.3%,急诊腔内治疗仅2例(3.6%)。
- 腔内治疗并发症包括1例肠系膜上动脉夹层致亚急性肠缺血、2例动脉瘤再灌注、1例支架血栓、1例脾巨大血肿。
- 开放手术并发症为4例移植物晚期血栓(5.8%),其中3例无症状,1例需脾切除。
临床怎么用
- 急诊VAA优先选择腔内治疗以降低死亡率。
- 择期VAA需综合动脉瘤大小、位置、形态、合并症及解剖条件选择开放或腔内治疗。
- 术后随访采用临床评估、多普勒超声和增强超声,必要时CT或MRI。
局限性
- 回顾性单中心设计,样本量有限,结果可能受选择偏倚影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Visceral artery aneurysms (VAAs), although rare, represent a life-threatening disease with high mortality rates. With the more frequent use of diagnostic tests, there has been an incidental detection of these lesions which are mostly asymptomatic. It follows that surgeons are increasingly called to decide on the most appropriate management of VAAs between an open surgical or endovascular approach and among the different endovascular options currently available. The aim of this retrospective study was to evaluate the results of open surgery and interventional endovascular strategies of visceral artery aneurysms with respect to technical success, therapy-associated complications, and postinterventional follow-up in the elective and emergency situation. METHODS: From January 1992 to January 2017, 125 open surgical or endovascular interventions for VAA were performed at our institution. Once the VAA was diagnosed and the indication for treatment was assessed, the preoperative diagnostic work-up consisted of contrast computed tomography (CT) or magnetic resonance imaging (MRI) and, in some patients, digital subtraction angiography. Follow-up included clinical and duplex ultrasound scan (DUS) and contrast-enhanced ultrasound to assess the treated vessel patency and organ perfusion after 1, 6, and 12 months, and yearly thereafter. CT or MRI controls were also performed at 1 year of follow-up and only when DUS was not diagnostic or showed a complication thereafter. After the first 5 years of follow-up, the status of the patient was obtained by a structured telephone survey. RESULTS: The treatment option was endovascular in 56 of 125 cases (44.8%). Technical success was 98.3%. In one case, the procedure was interrupted for the extensive dissection of the afferent vessel. Twenty-six patients were treated by coil embolization while 29 with covered stenting. The endovascular approach was in emergency in two cases (3.6%). In the endovascular group, mortality was nil. Complications occurred in 5 cases (8.9%): 1 subacute intestinal ischemia caused by superior mesenteric artery dissection, 2 aneurysm reperfusion, 1 stent thrombosis, and 1 massive splenic hematoma. In 69 (55.2%) cases, surgical treatment was preferred, with 24 VAA resections and 45 arterial reconstructions. In 20 cases (29%), open surgery was performed in emergency conditions. In the surgical group, 8 emergency patients (40%) died intraoperatively. The mortality after elective surgical interventions was nil. Complications after surgery were 4 graft late thrombosis (5.8%): asymptomatic in three cases and requiring splenectomy in one. CONCLUSIONS: There is no overall consensus regarding the indications for treatment of VAA. Currently in emergent setting, the endovascular approach should be considered as the first choice because of its reduced invasiveness, faster way to access and bleeding control; this accounts for the lower morality of the interventional therapy than open surgery. Endovascular approach is effective for elective repair of VAAs, but procedure-related complications may occur in a not negligible number of patients. Given comparable mortality rates and low procedure-related complication rate, surgical approach still has space in the elective management of VAAs, especially for aneurysms unsuitable or challenging for the endovascular option in patients with low surgical risk. The size, location, and morphology of VAAs, systemic or local comorbidities, and specific anatomical situations such as previous abdominal surgery should dictate treatment choice.
引用
- Martinelli O, Giglio A, Irace L, et al. Single-Center Experience in the Treatment of Visceral Artery Aneurysms. Ann Vasc Surg. 2019. PMID: 31009733. doi:10.1016/j.avsg.2019.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。